Ritonavir Has Reproductive Toxicity Depending on Disrupting PI3K/PDK1/AKT Signaling Pathway

Eun-Ju Jung1, Jae-Hwan Jo2, Claudine Uwamahoro1

  • 1Department of Animal Science and Biotechnology, Kyungpook National University, Sangju 37224, Gyeongsangbuk-do, Republic of Korea.

Toxics
|January 22, 2024
PubMed

Insights

Ritonavir (RTV) suppresses sperm function and viability by disrupting the PI3K/PDK1/AKT pathway. This study highlights RTV

Area of Science:

  • Reproductive Biology
  • Biochemistry
  • Pharmacology

Background:

  • Ritonavir (RTV), an antiviral used in COVID-19 treatments, also exhibits anti-cancer properties by inhibiting AKT signaling.
  • RTV can cause cytotoxicity and impair sperm function by altering AKT activity.
  • The specific mechanisms by which RTV affects AKT signaling in spermatozoa are not well understood.

Purpose of the Study:

  • To investigate the male reproductive toxicity of Ritonavir (RTV) in spermatozoa.
  • To elucidate the effects of RTV on the phosphoinositide 3-kinase/phosphoinositide-dependent protein kinase-1/protein kinase B (PI3K/PDK1/AKT) signaling pathway in sperm.

Main Methods:

  • Duroc spermatozoa were exposed to varying concentrations of RTV.
  • Sperm capacitation was induced.
  • Sperm functions (motility, kinematics, viability, capacitation, acrosome reaction) and protein expression (tyrosine phosphorylation, PI3K/PDK1/AKT pathway) were assessed.

Main Results:

  • RTV significantly reduced sperm motility, motion kinematics, capacitation, acrosome reaction rates, and cell viability.
  • RTV increased phospho-tyrosine protein levels and expression of PDK1/AKT pathway proteins, while decreasing PI3K levels.
  • AKT expression remained unchanged, but PI3K expression was significantly decreased.

Conclusions:

  • Ritonavir (RTV) impairs sperm function potentially through alterations in the PI3K/PDK1/AKT pathway, driven by increased tyrosine phosphorylation.
  • The findings suggest RTV possesses male reproductive toxicity that warrants consideration for prescribers and users.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K